Tatva Chintan to host Q1FY27 earnings call on July 17

0 min read Updated on 10 Jul 2026, 11:08 PM

Reviewed by

Anirudha BScanX News Team

AI Summary

Tatva Chintan Pharma Chem Ltd will conduct its Q1FY27 earnings call on July 17, 2026, at 5:00 PM IST, hosted by ICICI Securities. Managing Director Mr. Chintan Shah and CFO Mr. Ajesh Pillai will represent the company during the conference.

*this image is generated using AI for illustrative purposes only.

tatva chintan pharma has scheduled an earnings call to discuss its financial results for the quarter ended June 30, 2026. The conference call is set to take place on July 17, 2026, at 5:00 PM IST. This announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The call will be hosted by ICICI Securities. Management representatives including Mr. Chintan Shah, Managing Director, and Mr. Ajesh Pillai, Chief Financial Officer, will address the participants.

Key Details of the Earnings Call

Detail	Information
Event	Q1FY27 Results Conference Call
Date	Friday, July 17, 2026
Time	17:00 hrs India Time
Host	ICICI Securities

Participants can register for the Diamond Pass via the link provided in the invite. The company will upload the relevant information on its official website at www.tatvachintan.com .

Contact Points for Clarification

For any queries regarding the event, participants may reach out to the designated coordinators at ICICI Securities, including Mr. Rushad Kapadia and Ms. Seema Sehgal, among others listed in the invitation.

Historical Stock Returns for Tatva Chintan Pharma

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+7.04%	+4.65%	+14.35%	+4.49%	+38.95%	-42.63%

What are the expected key financial highlights for Q1FY27?

How will the company's performance impact its stock price?

What strategic initiatives will management discuss during the call?

Read Next Article

Tatva Chintan closes trading window for Q1FY27 results

0 min read Updated on 23 Jun 2026, 12:21 PM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

AI Summary

Tatva Chintan Pharma Chem Ltd has closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results declaration, complying with SEBI regulations to prevent insider trading.

*this image is generated using AI for illustrative purposes only.

Tatva Chintan Pharma Chem Ltd has closed its trading window for all designated persons and their immediate relatives, effective from July 1, 2026. The restriction will remain in place until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is implemented to prevent potential insider trading during the sensitive period preceding the financial announcement.

The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code on prohibition of insider trading. All designated persons and their immediate relatives have been advised to refrain from dealing in the securities of the company during this period.

The unaudited financial results for the quarter ending June 30, 2026, are expected to be released shortly. The trading window will reopen 48 hours after the results are made public, allowing designated persons to resume trading activities.